INBRX-101 Concentrate for Solution for Infusion 50mg/ml
INBRX101-01-202
Phase 2 small_molecule active
Quick answer
INBRX-101 Concentrate for Solution for Infusion 50mg/ml for Alpha-1 Antitrypsin Deficiency (AATD) Emphysema is a Phase 2 program (small_molecule) at Sanofi Pharma Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pharma Bristol-Myers Squibb
- Indication
- Alpha-1 Antitrypsin Deficiency (AATD) Emphysema
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active